Advanced Cancer Diagnostics Market

Advanced Cancer Diagnostics Market is segmented by Test Type (Imaging-Based Diagnostics, Tumor Marker Tests, FNAC and Biopsy, Liquid Biopsy, Genetic Testing, IHC and Molecular Testing, Bone Marrow Aspiration and Biopsy), End Use (Hospitals and Cancer Specialty Centers, Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Others), Technology (Genomic Analysis, Polymerase Chain Reaction, In Situ Hybridization, Immunohistochemistry, Liquid Biopsy, Proteomics), and Region, with forecasts covering the period from 2026 to 2036.